Etiology of Hyponatremia During IVIG Infusion
Hyponatremia during IVIG infusion occurs through two distinct mechanisms: pseudohyponatremia from hyperproteinemia-induced laboratory artifact, and true hyponatremia from osmotic water shifts caused by sucrose excipients combined with impaired free water excretion. 1, 2, 3
Primary Mechanisms
Pseudohyponatremia (Most Common)
IVIG therapy causes post-infusional hyperproteinemia that increases the non-aqueous phase of plasma, resulting in falsely low sodium measurements by indirect ion-selective electrode methods while the actual sodium concentration in plasma water remains normal 1, 3
This hyperproteinemia-induced pseudohyponatremia is accompanied by increased serum viscosity and an elevated osmolar gap 3
The FDA explicitly warns that it is clinically critical to distinguish true hyponatremia from pseudohyponatremia because treating pseudohyponatremia with fluid restriction can lead to volume depletion, further increased serum viscosity, and higher thrombosis risk 1
True Hyponatremia (Less Common but More Dangerous)
Sucrose-containing IVIG formulations cause osmotic translocation of water from the intracellular to extracellular compartment, diluting serum sodium concentration 2, 4
This mechanism is particularly problematic in patients with underlying defects in urinary free water excretion (such as SIADH, renal impairment, or those on diuretics) 2, 4
The large volume of relatively dilute IVIG fluid itself contributes additional free water load 2
Patients receiving isotonic maintenance IVFs can still develop hyponatremia if they receive IV medications containing free water or consume additional free water enterally 5
Risk Factors for IVIG-Induced Hyponatremia
- Advanced age 4
- Pre-existing renal impairment 4
- Use of diuretics 4
- Diabetes mellitus 4
- Underlying conditions causing elevated arginine vasopressin (pain, nausea, stress, postoperative state, hypovolemia, pulmonary or CNS disorders) 5
Clinical Significance
Serum sodium typically falls by 5.7 mmol/L in patients who develop acute renal failure from IVIG versus 2.7 mmol/L in those without renal complications 4
There is a strong inverse correlation between changes in serum sodium and creatinine (r = -0.308; p < 0.01), indicating that the degree of hyponatremia depends on the extent of IVIG nephropathy 4
Translocational hyponatremia and associated hyperkalemia, while usually clinically insignificant in patients with normal renal function, can be dangerous in those with severely compromised renal function due to impaired sucrose excretion 4
Sodium Content of IVIG Preparations
IVIG preparations containing high sodium (0.9%) increase serum sodium levels post-infusion, while preparations containing trace sodium do not 6
In patients with pre-existing hyponatremia (such as in Kawasaki disease), IVIG products without sodium can worsen hyponatremia, though their therapeutic efficacy appears equivalent to sodium-containing preparations 6
Monitoring Recommendations
Baseline assessment of blood viscosity should be considered in patients at risk for hyperviscosity (those with cryoglobulins, markedly elevated triglycerides, or monoclonal gammopathies) 1
If patients receiving isotonic maintenance IVFs develop hyponatremia, evaluate for other sources of free water or possible SIADH/adrenal insufficiency 5
Measure plasma osmolality to distinguish true hyponatremia from pseudohyponatremia 1, 3